[News Article]Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at 9TH CLINICAL TRIALS INNOVATION PROGRAMME on April 26-27, 2018.
14 Jan 2019
``Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2``...
Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at Asia Pharma R&D Leaders Summit 2018 on April 17-18, 2018.
PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a keynote presentation at 9TH CLINICAL TRIALS INNOVATION PROGRAMME on April 26-27, 2018.
https://worldbi.co.uk/CTIPEU/speakers.php
Event: 9TH CLINICAL TRIALS INNOVATION PROGRAMME
Presentation Date: Thursday, April 26th, 2018
Presentation Time: 12:10 - 12:40 PM
Location: Frankfurt, GERMANY
For investors attending the 9TH CLINICAL TRIALS INNOVATION PROGRAMME, please contact PharmAbcine Investor Relations and business development to schedule a meeting with management at sungwoo.kim@pharmabcine.com.